Since the aberrant expression and/or interactions of regulatory RNAs in cancer impact MHC gene expression, they do have an influence on different HLA class I altered phenotypes (Table 1) and consequently should be included in the disrupted expression of HLA class I molecules in cancer. This evidence concerns the gene HLA-C and cancer.